Overview

A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the safety and tolerability of multiple doses of TBA-354 in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Global Alliance for TB Drug Development